Maintaining GLP-1 Weight Loss Through Body Devices
Dr Marwa Ali examines the role of body devices in GLP-1–associated weight loss The use of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and tirzepatide, has grown rapidly in medical weight management.¹ With patients achieving significant weight loss and …
Subscriber content
Continue reading this clinical article
To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.
Already a subscriber? Log in